The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA (Q73304026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A N Pedersen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Høyer-Hansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Brünner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G M Clark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B Larsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H S Poulsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Danø

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunological Methods

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

55-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activator inhibitors: hormonally regulated serpins

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Improved medium for extraction of plasminogen activator from tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

The use of avidin-biotin interaction in immunoenzymatic techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Proenzyme to urokinase-type plasminogen activator in the mouse in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Type-1 plasminogen activator inhibitor in human breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

A better cell line for making hybridomas secreting specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2897%2900008-2

10.1016/S0022-1759(97)00008-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9134030%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference